Ukrainian girl, 7, with rare cancer who flew to Israel for a cure is killed by Iranian strike
A seven-year-old Ukrainian girl who was diagnosed with a rare cancer and moved to Israel in hope of a cure has been killed by an Iranian air strike.
Nastya Buryk died alongside members with her family in Bat Yam last week when a missile fired by the Islamic regime struck their apartment block.
Nastya, her mother, grandmother and two brothers, were all killed in the blast on June 13, the first night of Iran's barrage, it was reported by Israeli news outlet Ynet.
Her father, Artem, who is fighting against Russian invaders in Kyiv, remains alive.
She had been undergoing treatment for lymphoblastic leukaemia, a rare cancer that attacks blood and bone marrow.
Nastya, from Odesa, was first diagnosed in 2022 and underwent chemotherapy in Ukraine. Her condition improved but she later relapsed.
'On August 29, 2022, we heard the terrible news: 'Your daughter has cancer,'' her mother Maria Peshkureva wrote on social media.
'Since that day, I have been living in a parallel reality, where the main thing is to save. To breathe. To not give up.'
As her health worsened, her family searched for more specialist treatment and, thanks to charitable donations, they sought medical care in Israel, where Nastya had a bone marrow transplant.
The procedure was unsuccessful and her leukaemia returned.
Earlier this year, her family turned to a new treatment in Israel, while her grandmother, Olena, 60, and two brothers, Konstantin and Ilya, nine and 13, flew from Ukraine to be with her. Both of the boys attended a local school.
Nastya's father, who joined Ukraine's 95th Airborne Assault Brigade in 2022, recorded videos from the front line to appeal for donations as the cost of his daughter's care escalated.
Her family believed they would be safer in Israel than Odesa, which has suffered deadly shelling from Russian forces.
Ukraine's embassy in Israel said: 'On June 14, five Ukrainian citizens, including three minors, were killed in a massive Iranian missile attack on Israel, with a missile hitting a residential building in the city of Bat Yam.
'Ukrainian diplomats and consuls are in close contact with the police and other services to identify and organise the process of returning the bodies of the dead.'
The attack on Bat Yam also killed four other people and injured more than 100.
Since June 13, Iran has fired missiles at Israel every day in response to Israel's 'pre-emptive strike' on the regime's nuclear facilities on June 12.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
3 hours ago
- The Independent
Sarcoma is an aggressive form of cancer. Here's key symptoms to know
Sarcoma is an aggressive but less recognised cancer affecting connective tissues like nerves, bones, and fat cells, with around 5,300 diagnoses annually in the UK. Public awareness of sarcoma remains low due to its relative rarity and less descriptive name compared to more common cancers. Key symptoms include a growing or changing lump for soft tissue sarcomas, persistent bone pain for bone sarcomas, and subtle signs like bloating or internal bleeding for GISTs. Diagnosis typically involves imaging such as ultrasound, X-ray, and MRI, followed by a crucial biopsy to determine the specific subtype for effective treatment planning. The primary treatment for sarcoma is surgery to remove the tumor, often combined with chemotherapy or radiotherapy, with early diagnosis significantly improving patient outcomes. The truth about the aggressive type of cancer you've probably not heard of
Telegraph
7 hours ago
- Telegraph
Ukrainian girl, 7, with rare cancer who flew to Israel for a cure is killed by Iranian strike
A seven-year-old Ukrainian girl who was diagnosed with a rare cancer and moved to Israel in hope of a cure has been killed by an Iranian air strike. Nastya Buryk died alongside members with her family in Bat Yam last week when a missile fired by the Islamic regime struck their apartment block. Nastya, her mother, grandmother and two brothers, were all killed in the blast on June 13, the first night of Iran's barrage, it was reported by Israeli news outlet Ynet. Her father, Artem, who is fighting against Russian invaders in Kyiv, remains alive. She had been undergoing treatment for lymphoblastic leukaemia, a rare cancer that attacks blood and bone marrow. Nastya, from Odesa, was first diagnosed in 2022 and underwent chemotherapy in Ukraine. Her condition improved but she later relapsed. 'On August 29, 2022, we heard the terrible news: 'Your daughter has cancer,'' her mother Maria Peshkureva wrote on social media. 'Since that day, I have been living in a parallel reality, where the main thing is to save. To breathe. To not give up.' As her health worsened, her family searched for more specialist treatment and, thanks to charitable donations, they sought medical care in Israel, where Nastya had a bone marrow transplant. The procedure was unsuccessful and her leukaemia returned. Earlier this year, her family turned to a new treatment in Israel, while her grandmother, Olena, 60, and two brothers, Konstantin and Ilya, nine and 13, flew from Ukraine to be with her. Both of the boys attended a local school. Nastya's father, who joined Ukraine's 95th Airborne Assault Brigade in 2022, recorded videos from the front line to appeal for donations as the cost of his daughter's care escalated. Her family believed they would be safer in Israel than Odesa, which has suffered deadly shelling from Russian forces. Ukraine's embassy in Israel said: 'On June 14, five Ukrainian citizens, including three minors, were killed in a massive Iranian missile attack on Israel, with a missile hitting a residential building in the city of Bat Yam. 'Ukrainian diplomats and consuls are in close contact with the police and other services to identify and organise the process of returning the bodies of the dead.' The attack on Bat Yam also killed four other people and injured more than 100. Since June 13, Iran has fired missiles at Israel every day in response to Israel's 'pre-emptive strike' on the regime's nuclear facilities on June 12.
Telegraph
7 hours ago
- Telegraph
Cancer patients warned not to use weight-loss jabs
Cancer patients should not take 'quick fix' weight-loss jabs unless under specialist care, experts have warned. Macmillan Cancer Support said there had been a surge in people asking about the drugs, such as Wegovy and Mounjaro, but that there was not enough evidence about how they might affect cancer treatment. It said there was already evidence the injections may affect how other medicines are absorbed by the body, and that this could include cancer drugs. The manufacturers acknowledge the weight-loss jabs may affect the absorption of other drugs. The contraceptive pill and hormone replacement therapy (HRT) are among treatments experts have said are affected when taken orally. It is thought the mechanism by which the drugs make a person feel fuller and reduce their appetite – called delayed gastric emptying – also slows down the rate at which medicines are absorbed by the gut. Dr Owen Carter, national clinical adviser at Macmillan Cancer Support, said there had been 'a noticeable increase in calls to Macmillan's free support line and a flurry of messages on our peer-to-peer online community about weight-loss drugs'. 'We know that cancer affects everybody differently and it's understandable that lots of people are interested in new drugs which accelerate weight loss, particularly if they want to manage their weight before or after treatment for cancer,' he said. 'While 'quick fixes' may seem attractive, we simply do not know enough about the long-term impact of these weight-loss medications to recommend them if they're not prescribed by a specialist.' He also said that 'certain weight-loss medications carry warnings about a potential link with thyroid cancer'. He added that 'eating well and staying as active as possible are proven to help people feel better, increase their energy levels and strengthen their immune systems, which can help them to manage their weight and cope better with cancer treatment'. Weight-loss drugs have been available on the NHS to a select few patients via specialist weight management clinics. The majority of the estimated 1.5 million people taking the drugs in the UK are accessing them privately for around £200 a month, often from online pharmacies. Later this month, GPs will be able to prescribe one of the drugs, Mounjaro, to obese patients. Last week, Prof Sir Stephen Powis, the NHS England national medical director, said they could be as transformative as statins.
